Pancreatic islet blood flow is selectively enhanced by captopril, irbesartan and pravastatin, and suppressed by palmitate
- 1 July 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 346 (1) , 26-32
- https://doi.org/10.1016/j.bbrc.2006.05.144
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Inflammation and the etiology of type 2 diabetesDiabetes/Metabolism Research and Reviews, 2005
- Endothelial inflammation in insulin resistanceThe Lancet, 2005
- Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 DiabetesNew England Journal of Medicine, 2003
- Global and societal implications of the diabetes epidemicNature, 2001
- LOCAL BLOOD FLOW REGULATION IN TRANSPLANTED RAT PANCREATIC ISLETSTransplantation, 2000
- Inhibition by simvastatin, but not pravastatin, of glucose‐induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L‐type Ca2+ channels in rat islet β‐cellsBritish Journal of Pharmacology, 1999
- Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatinAtherosclerosis, 1997
- Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemiaAtherosclerosis, 1996
- Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patientsThe Lancet, 1993
- A rapid method of visualizing the pancreatic islets for studies of islet capillary blood flow using non‐radioactive microspheresActa Physiologica Scandinavica, 1981